Clinical trials
Recruiting Phase 3 Diabetes Mellitus, Type 2 trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
53 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2022 | 2 |
| 2023 | 4 |
| 2024 | 8 |
| 2025 | 10 |
| 2026 | 29 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 53 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AstraZeneca | 8 |
| Novo Nordisk A/S | 4 |
| EMS | 3 |
| Eli Lilly and Company | 3 |
| Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. | 3 |
| Hoffmann-La Roche | 3 |
| Boehringer Ingelheim | 2 |
| The United Bio-Technology (Hengqin) Co., Ltd. | 2 |
| Amgen | 1 |
| Ascletis Pharma (China) Co., Limited | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Diabetes Mellitus, Type 2 | 53 |
| Obesity | 11 |
| Overweight | 10 |
| Hypertension | 3 |
| Cardiovascular Diseases | 2 |
| Diabetes Mellitus | 2 |
| Diabetes, Gestational | 2 |
| Dyslipidemias | 2 |
| Endocrine System Diseases | 2 |
| Glucose Metabolism Disorders | 2 |
Trials
Showing 1 to 25 of 53. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.